Self-assembling tetrameric peptides allow in situ 3D bioprinting under physiological conditions

Area of Science:

• Biotechnology
• Materials Science
• Cell Biology

Background:

• Traditional bioprinting methods often involve harsh conditions that can stress cells.
• Developing bioinks that support cell viability and function under physiological conditions is crucial for tissue engineering.

Purpose of the Study:

• To develop an in situ bioprinting method using self-assembling ultrashort peptides as bioinks.
• To demonstrate the incorporation of nanomaterials into peptide scaffolds for enhanced functionality.

Main Methods:

• Utilized self-assembling ultrashort peptides as bioinks for in situ bioprinting.
• Applied the bioprinting method under true physiological conditions, avoiding UV-treatment and chemical crosslinking.
• Synthesized or incorporated various nanomaterials into the 3D bioprinted peptide scaffolds.

Main Results:

• Successfully bioprinted cells under physiological conditions using peptide bioinks.
• The developed method avoids cell-damaging processes common in other bioprinting techniques.
• Demonstrated facile synthesis and incorporation of nanomaterials into 3D peptide scaffolds, enabling functionalization.

Conclusions:

• The novel in situ bioprinting method offers a gentle and effective approach for cell encapsulation and tissue fabrication.
• The use of self-assembling peptide bioinks facilitates the creation of functionalized 3D scaffolds with potential applications in regenerative medicine.
• This technique paves the way for advanced 3D bioprinting strategies that better mimic native cellular environments.